Selected Podcast

FDA WARNINGS ABOUT XELJANX (ARTHRITIS MEDICATION)

Dr. George Munoz discusses FDA warnings about a powerful Arthritis medication (Xeljanx) and risks of both heart disease and possibly cancer risk. What does it mean for patients and physicians?
FDA WARNINGS ABOUT XELJANX (ARTHRITIS MEDICATION)
Featuring:
George Munoz, MD

George Muñoz, MD, is a board-certified rheumatologist and internist, fellowship trained in rheumatology/immunology at Harvard Medical School affiliates the Brigham and Women’s Hospital and the Beth Israel Hospital in Boston. He completed a second fellowship in integrative medicine at the University of Arizona Center for Integrative Medicine founded by Andrew Weil, MD, and was the first recipient of the Jones/Lovell Rheumatology Scholar Award for 2006-2008. He is a national speaker, lecturer, published author, and co-editor. He serves as chief of integrative medicine and integrative rheumatology for the American Arthritis and Rheumatology Associates (AARA), the largest rheumatology super-group in the US. He is a futurist and innovator, “specializing in the patient journey and experience” as a cornerstone and guiding principal for healthcare stakeholders to emulate and innovate. 


Learn more about George Munoz, MD